Labcorp (LH) Stock Forecast & Price Target

Labcorp
Bull Case

Here are some ways that investors could benefit from investing in Laboratory Co. of America Holdings:

• Laboratory Co. of America Holdings recently reported second-quarter 2026 earnings that exceeded market expectations, delivering $4.99 in earnings per share compared to the consensus estimate of $4.78, while revenue of $3.73 billion also surpassed the projected $3.71 billion, demonstrating strong operational performance and the ability to outperform analyst forecasts.
• The company has received a consensus recommendation of "Moderate Buy" from twelve analysts, with an average price target of $337.73, which represents significant upside potential from the current stock price of $308.57, indicating that financial professionals believe the stock is undervalued relative to its future earnings potential.
• Laboratory Co. of America Holdings maintains a consistent track record of beating earnings estimates, having also exceeded expectations in the first quarter of 2026 with $4.25 in earnings per share against a consensus of $4.09, suggesting reliable execution and strong demand for its diagnostic testing services.
• The stock recently crossed above its 200-day moving average, a technical indicator that often signals a shift from a bearish to a bullish trend, as the share price of $308.56 surpassed the average trading price of $284.90 over the past year, suggesting increased investor confidence and momentum.
• The company offers a stable dividend yield of 0.95% with a low payout ratio of 23.82%, meaning it retains the majority of its earnings for reinvestment and growth while still providing a steady income stream to shareholders, which is attractive for long-term investors seeking both capital appreciation and cash flow.